Siegel RL, Miller KD, Wagle NS, et al. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.
Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624–39. https://doi.org/10.1038/s41571-023-00798-3.
Hill W, Lim EL, Weeden CE, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67. https://doi.org/10.1038/s41586-023-05874-3.
Article CAS PubMed PubMed Central Google Scholar
Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46. https://doi.org/10.1158/2159-8290.Cd-21-1059.
Article CAS PubMed Google Scholar
Wang Y, Qian F, Hu M, et al. Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer. Eur J Cardio-Thorac Surg: Off J Eur Assoc Cardio-Thoracic Surg. 2021;59(3):617–23. https://doi.org/10.1093/ejcts/ezaa353.
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer. 2011;6(2):244–85. https://doi.org/10.1097/JTO.0b013e318206a221.
Zheng X, Wu Y, Zuo H, et al. Metal nanoparticles as novel agents for lung cancer diagnosis and therapy. Small. 2023;19(18):e2206624. https://doi.org/10.1002/smll.202206624.
Article CAS PubMed Google Scholar
Hao D, Han G, Sinjab A, et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 2022;12(11):2626–45. https://doi.org/10.1158/2159-8290.Cd-21-1658.
Article CAS PubMed PubMed Central Google Scholar
Zhang F, Guo W, Zhou B, et al. Three-year follow-up of neoadjuvant programmed cell death protein-1 inhibitor (Sintilimab) in NSCLC. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer. 2022;17(7):909–20. https://doi.org/10.1016/j.jtho.2022.04.012.
Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer. Lung. 2020;198(6):897–907. https://doi.org/10.1007/s00408-020-00407-5.
Article PubMed PubMed Central Google Scholar
Wu J, Lin Z. Non-small cell lung cancer targeted therapy: drugs and mechanisms of drug resistance. Int J Mol Sci. 2022;23(23):15056. https://doi.org/10.3390/ijms232315056.
Article CAS PubMed PubMed Central Google Scholar
Krall AS, Xu S, Graeber TG, et al. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat Commun. 2016;7:11457. https://doi.org/10.1038/ncomms11457.
Article CAS PubMed PubMed Central Google Scholar
Shen X, Jain A, Aladelokun O, et al. Asparagine, colorectal cancer, and the role of sex, genes, microbes, and diet: a narrative review. Front Mol Biosci. 2022;9:958666. https://doi.org/10.3389/fmolb.2022.958666.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Shi T, Cui X, et al. Asparagine reinforces mTORC1 signaling to boost thermogenesis and glycolysis in adipose tissues. The EMBO J. 2021;40(24):e108069. https://doi.org/10.15252/embj.2021108069.
Article CAS PubMed Google Scholar
Chiu M, Taurino G, Bianchi MG, et al. Asparagine synthetase in cancer: beyond acute lymphoblastic leukemia. Front Oncol. 2019;9:1480. https://doi.org/10.3389/fonc.2019.01480.
Knott SRV, Wagenblast E, Khan S, et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nat. 2018;554(7692):378–81. https://doi.org/10.1038/nature25465.
Lorenzi PL, Reinhold WC, Rudelius M, et al. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Mol Cancer Ther. 2006;5(11):2613–23. https://doi.org/10.1158/1535-7163.Mct-06-0447.
Article CAS PubMed Google Scholar
Jiang J, Batra S, Zhang J. Asparagine: a metabolite to be targeted in cancers. Metabolites. 2021;11(6):402. https://doi.org/10.3390/metabo11060402.
Article CAS PubMed PubMed Central Google Scholar
Pavlova NN, Hui S, Ghergurovich JM, et al. As extracellular glutamine levels decline, asparagine becomes an essential amino acid. Cell Metab. 2018;27(2):428-438.e425. https://doi.org/10.1016/j.cmet.2017.12.006.
Article CAS PubMed PubMed Central Google Scholar
Du F, Chen J, Liu H, et al. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death Dis. 2019;10(3):239. https://doi.org/10.1038/s41419-019-1481-9.
Article CAS PubMed PubMed Central Google Scholar
Shen X, Cai Y, Lu L, et al. Asparagine metabolism in tumors is linked to poor survival in females with colorectal cancer: a cohort study. Metabolites. 2022;12(2):164. https://doi.org/10.3390/metabo12020164.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Xia Z, Sun X, et al. Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer. Front Immunol. 2023;14:1111319. https://doi.org/10.3389/fimmu.2023.1111319.
Article CAS PubMed PubMed Central Google Scholar
Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47. https://doi.org/10.1093/nar/gkv007.
Article CAS PubMed PubMed Central Google Scholar
Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–13. https://doi.org/10.1093/nar/gky1131.
Article CAS PubMed Google Scholar
Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504. https://doi.org/10.1101/gr.1239303.
Article CAS PubMed PubMed Central Google Scholar
Zhou G, Soufan O, Ewald J, et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234–41. https://doi.org/10.1093/nar/gkz240.
Article CAS PubMed PubMed Central Google Scholar
Zeng D, Ye Z, Shen R, et al. IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975. https://doi.org/10.3389/fimmu.2021.687975.
Article CAS PubMed PubMed Central Google Scholar
Becht E, Giraldo NA, Lacroix L, et al. Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):249.
留言 (0)